TSM Brands Isopropyl Alcohol Recalled for Undeclared Ethyl Alcohol
TSM Brands LLC is recalling Luxury 70% Isopropyl Alcohol bottles nationwide because the product contains undeclared ethyl alcohol that is not identified on the label.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a labeling defect—specifically an undeclared ingredient. The source text does not report any illnesses or injuries, making this a labeling error without reported harm, which falls under the Moderate category.
Plain-English summary
TSM Brands LLC is recalling Luxury 70% Isopropyl Alcohol, 16 FL. OZ. (473 ML) bottles distributed nationwide. The product contains undeclared ethyl alcohol—an ingredient not listed on the label.
The affected product is identified by UPC 868275965734 and includes lot numbers 339 through 399. Approximately 135,444 bottles were distributed across the United States.
Consumers who have purchased this product should stop using it. Anyone with questions about the recall may contact the manufacturer, TSM Brands LLC, located at 540 Equinox Ln, Manalapan, NJ 07726.
The recalled product
- Product
- Luxury 70% Isopropyl Alcohol, 16 FL. OZ. (1PT) 473 ML bottle, Distributed by: TSM Brands LLC, 540 Equinox Ln, Manalapan, NJ 07726, UPC 868275965734.
- Manufacturer
- Tsm Brands LLC
- Category
- Drug — Topical / Antiseptic
- Hazard
- undeclared-ingredient
- labeling-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot#:339
- 340
- 341
- 342
- 343
- 344
- 345
- 346
- 347
- 348
- 349
- 350
- 351
- 352
- 353
- 354
- 355
- 356
- 357
- 358
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27